We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Haematology
Digital Poster
Clinical
Comprehensive analysis of uveal MALT lymphomas: epidemiological insights and radiotherapy utilization from the SEER database
Pierre Loap, France
E25-991
Clinical outcome and health-related quality of life after chemo-immunotherapy and ISRT in early nodal DLBCL- long-term results of a phase II trial
Ahitagni Biswas, United Kingdom
E25-3920
Different scenarios of radiotherapy in CAR T-cell therapy: A single Institution experience
Maria Piedra Argudo, Spain
E25-3972
RADIATION THERAPY IN PRIMARY CUTANEOUS LYMPHOMAS PATIENTS: IMPACT OF “LOW” AND “HIGH” DOSES.
Roberta MUNI, Italy
E25-4412
Risk of Neutropenia With or Without Daratumumab in Bortezomib-Based First-Line Chemotherapy and Radiotherapy for Multiple Myeloma: A Pilot Study
Mateusz Pajdziński, Poland
E25-4474
Patients’ prioritizing of quality or length of life and travel distance of primary cutaneous lymphoma patients referred to radiotherapy
Khaled Elsayad, Germany
E25-1128
Use of Unity MRI-linac for the treatment of non-Hodgkin lymphoma head and neck sites: preliminary experience from a prospective observational study.
Andrea Guerini, Italy
E25-2022
Retrospective analysis of toxicities after total body irradiation without lung shielding
Justin Nguyen, Belgium
E25-2168
2D TOTAL BODY IRRADIATION: THE END OF AN ERA AT OUR CENTER.
Celia Nicolas-Boluda, Spain
E25-2452
Outcomes of two or more hematopoietic stem cell transplantations with total body irradiation for hematologic malignancies
Keiko Murofushi, Japan
E25-2506
Results of cutaneous lymphomas treated with radiotherapy
Gemma Calvet Molinas, Spain
E25-3593